Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-((3-(((4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl)amino)propyl)amino)thieno(3,2-b)pyridin-7(4h)-one
2. Crs3123
3. Rep 3123
4. Rep-3123
5. Rep3123
6. Thieno(3,2-b)pyridin-7(4h)-one, 5-((3-(((4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl)amino)propyl)amino)-
1. Crs-3123
2. Crs3123
3. Rep3123
4. Rep-3123
5. 2p987fw4e8
6. 1013915-71-3
7. Cid 16744283
8. 5-[(3-{[(4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl]amino}propyl)amino]thieno[3,2-b]pyridin-7(6h)-one
9. 5-((3-(((4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl)amino)propyl)amino)thieno(3,2-b)pyridin-7(4h)-one
10. 5-[(3-{[(4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl]amino}propyl)amino]thieno[3,2-b]pyridin-7(4h)-one
11. Schembl571285
12. Unii-2p987fw4e8
13. Chembl4297370
14. Gtpl10991
15. Zinc43173277
16. Db12262
17. Ncgc00386617-01
18. Hy-18324
19. Cs-0007431
20. Q27255381
21. Thieno(3,2-b)pyridin-7(4h)-one, 5-((3-(((4r)-6,8-dibromo-3,4-dihydro-2h-1-benzopyran-4-yl)amino)propyl)amino)-
22. U81
| Molecular Weight | 513.2 g/mol |
|---|---|
| Molecular Formula | C19H19Br2N3O2S |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 512.95442 g/mol |
| Monoisotopic Mass | 510.95647 g/mol |
| Topological Polar Surface Area | 90.6 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 579 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
78
PharmaCompass offers a list of CRS3123 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CRS3123 manufacturer or CRS3123 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CRS3123 manufacturer or CRS3123 supplier.
PharmaCompass also assists you with knowing the CRS3123 API Price utilized in the formulation of products. CRS3123 API Price is not always fixed or binding as the CRS3123 Price is obtained through a variety of data sources. The CRS3123 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CRS3123 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CRS3123, including repackagers and relabelers. The FDA regulates CRS3123 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CRS3123 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CRS3123 supplier is an individual or a company that provides CRS3123 active pharmaceutical ingredient (API) or CRS3123 finished formulations upon request. The CRS3123 suppliers may include CRS3123 API manufacturers, exporters, distributors and traders.
click here to find a list of CRS3123 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CRS3123 DMF (Drug Master File) is a document detailing the whole manufacturing process of CRS3123 active pharmaceutical ingredient (API) in detail. Different forms of CRS3123 DMFs exist exist since differing nations have different regulations, such as CRS3123 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CRS3123 DMF submitted to regulatory agencies in the US is known as a USDMF. CRS3123 USDMF includes data on CRS3123's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CRS3123 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CRS3123 suppliers with USDMF on PharmaCompass.
CRS3123 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CRS3123 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CRS3123 GMP manufacturer or CRS3123 GMP API supplier for your needs.
A CRS3123 CoA (Certificate of Analysis) is a formal document that attests to CRS3123's compliance with CRS3123 specifications and serves as a tool for batch-level quality control.
CRS3123 CoA mostly includes findings from lab analyses of a specific batch. For each CRS3123 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CRS3123 may be tested according to a variety of international standards, such as European Pharmacopoeia (CRS3123 EP), CRS3123 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CRS3123 USP).
